LMG Life Sciences Americas 2024: research cycle open

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Americas 2024: research cycle open

Life Sciences website image 2024.png

The Americas research cycle has commenced. Do not miss this opportunity to nominate your work!

LMG Life Sciences is excited to announced the launch of the 2024 Americas research. We continue to recognize the top firms, lawyers, and legal work serving the Life Sciences industry from across the United States, Canada, and select jurisdictions within Latin America.

The deadline for submissions is 31 May 2024.

You can find detailed information about the rankings and awards by reviewing the methodology or reading the FAQs.

The full list of categories for the rankings and awards can be found on the LMG Life Sciences website.

Important Dates:

Submissions Open

Submissions Close

Shortlist Published

Gala Ceremony

Rankings Published

11 April 2024

31 May 2024

July 2024


September 2024

September 2024


All research submissions must be entered through our dedicated submissions platform. Submissions made in any other format or emailed to us will not be accepted.

For any questions about the awards and/or the rankings research, please contact Research Editor, John Harrison and Research Analyst, Jose Martinez.

For queries about business development and commercial opportunities, please contact George Reeves.

Please note that LMG Life Sciences is a sister publication to and supported by Managing IP but run independently to the IPSTARS research.

more from across site and SHARED ros bottom lb

More from across our site

A decision on a licensing rate payable by Warner Bros and Paramount, and a survey outlining UK businesses’ lack of IP preparation ahead of launching abroad, were among other major talking points
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
Gift this article